On March 25, 2026, Jiang Li and their colleagues from the Ocean University of China published an article in the journal Marine Drugs titled "Molecular Characterization and Mechanistic Insights of a Thermostable Neoagarobiose Hydrolase Aga2457 from Alteromonas sp." The study investigates a novel enzyme designated as Aga2457, derived from the Indonesian marine bacterium Alteromonas sp. Aga1552. This paper details the cloning, heterologous expression, and rigorous biochemical characterization of this neoagarobiose hydrolase (NABH). The core finding is the identification of a thermostable enzyme that specifically cleaves the α-1,3-glycosidic bond of neoagarobiose (NA2), yielding 3,6-anhydro-L-galactose (L-AHG) and D-galactose. This discovery is pivotal because L-AHG is a rare sugar with potent antioxidant, anti-inflammatory, and skin-whitening properties, and Aga2457 provides a robust biological "key" to unlock this value from seaweed biomass at an industrial scale.
To appreciate the significance of Aga2457, one must understand the structural complexity of marine glycans. Agarose is a linear polymer made of repeating units of L-agarobiose, consisting of alternating 3-linked β-D-galactopyranose and 4-linked 3,6-anhydro-α-L-galactopyranose. The degradation of this polymer in nature is a collaborative effort. First, β-agarases (such as those from the GH16 family) break the polymer into neoagarooligosaccharides (NAOS). However, these NAOS themselves are not particularly useful for metabolic fermentation or high-value applications. The "bottleneck" in the process has always been the conversion of the dimer, neoagarobiose, into monomeric sugars. This is the specific role of GH117 neoagarobiose hydrolases.
Until recently, very few GH117 enzymes had been characterized, and even fewer possessed the stability required for industrial use. Marine bacteria like Alteromonas sp. have evolved these specialized enzymes to survive in nutrient-poor oceanic environments by efficiently scavenging every bit of carbon from drifting seaweed. By tapping into this evolutionary expertise, the authors of this paper have provided a tool that mimics nature's efficiency in a controlled, industrial setting.
The research team performed a multi-faceted analysis that is categorized into three distinct phases of discovery: biochemical optimization, kinetic proficiency, and structural-mechanistic mapping.
The journey began with the heterologous expression of the aga2457 gene in Escherichia coli BL21 (DE3). The purified recombinant enzyme, with a molecular weight of approximately 42 kDa, underwent exhaustive testing to determine its "sweet spot" for industrial application.
Fig.1 Biochemical properties of Aga2457. (Li, et al., 2026)
The second phase of the research focused on the "how fast" and "how specific" aspects of the enzyme. The researchers employed high-performance liquid chromatography (HPLC) to monitor the degradation of neoagarooligosaccharides.
Fig.2 HPLC of hydrolysis products produced by Aga2457. (Li, et al., 2026)
To truly master an enzyme, one must understand its architecture. Using advanced computational tools, including AlphaFold and molecular docking, the researchers provided a 3D blueprint of Aga2457.
Fig.3 Predicted 3D structure of Aga2457. (Li, et al., 2026)
The study of Aga2457 is more than just a biochemical report; it is a vital piece of the puzzle for the Blue Bioeconomy. The ability to produce 3,6-anhydro-L-galactose (L-AHG) and D-galactose from macroalgae has profound implications:
In conclusion, Aga2457 stands out as a robust, efficient, and thermostable catalyst that overcomes previous limitations in agar processing. This research not only advances our fundamental knowledge of carbohydrate metabolism in marine bacteria but also provides a tangible technology for the sustainable exploitation of the ocean's glycan wealth. As we continue to explore the marine "glycome," enzymes like Aga2457 will be the catalysts that transform marine waste into global wealth.
Reference